These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 5954638)

  • 1. Cholesterol in the cerebrospinal fluid. An analysis of 447 neurological patients.
    Tichý J
    Rev Czech Med; 1966; 12(4):265-71. PubMed ID: 5954638
    [No Abstract]   [Full Text] [Related]  

  • 2. [The lipids of normal and pathological cerebrospinal fluid].
    Pilz H
    Schriftenr Neurol; 1970; 4():1-123. PubMed ID: 4940123
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative analysis of cerebrospinal fluid immunoglobulins in various neurological diseases.
    Hirohata S; Inoue T; Iwamoto S; Hirose S; Miyamoto T
    Arerugi; 1984 Apr; 33(4):242-6. PubMed ID: 6383275
    [No Abstract]   [Full Text] [Related]  

  • 4. The cholesterol and cholesterol ester content of cerebrospinal fluid in patients with multiple sclerosis and other neurological diseases.
    GREEN JB; PAPADOPOULOS N; CEVALLOS W; FORSTER FM; HESS WC
    J Neurol Neurosurg Psychiatry; 1959 May; 22(2):117-9. PubMed ID: 13655100
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cerebrospinal fluid polyamine in various neurological diseases].
    Miyazaki M; Tanaka Y; Matsushima S; Okada M; Waga S
    Rinsho Shinkeigaku; 1986 May; 26(5):471-8. PubMed ID: 3742900
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of dopamine-releasing protein (DARP) in cerebrospinal fluid of patients with neurological disorders.
    Verdugo-Diaz L; Morgado-Valle C; Solis-Maldonado G; Drucker-Colin R
    Arch Med Res; 1997; 28(4):577-81. PubMed ID: 9428587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IgG determination in the cerebrospinal fluid--correlation of these results with other cerebrospinal fluid values].
    Lehmitz R; Olischer RM; Wenk ED
    Psychiatr Neurol Med Psychol (Leipz); 1981 Jan; 33(1):10-8. PubMed ID: 6164070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measurement of methionine-enkephalin-like immunoreactivity in the cerebrospinal fluid of various neurological patients].
    Suga H; Fujiyoshi K; Okamoto K; Nakamura S; Kameyama M
    Rinsho Shinkeigaku; 1984 Sep; 24(9):867-71. PubMed ID: 6518709
    [No Abstract]   [Full Text] [Related]  

  • 9. [Neuron-specific enolase and S-100 protein levels in the cerebrospinal fluid of the patients with neurological diseases].
    Mokuno K; Kato K; Kawai K; Matsuoka Y; Sobue I
    Rinsho Shinkeigaku; 1983 May; 23(5):397-403. PubMed ID: 6883882
    [No Abstract]   [Full Text] [Related]  

  • 10. Trace elements in the cerebrospinal fluid in neurological diseases.
    Kjellin KG
    Clin Toxicol; 1981 Nov; 18(11):1237-45. PubMed ID: 7341049
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative determination of cerebrospinal fluid (CSF) cholesterol by thin layer chromatography (TLC).
    Trbojević-Cepe M; Arko K
    Neurologija; 1977; 25(3-4):39-55. PubMed ID: 755229
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chromatographic determination of phospholipids in the cerebrospinal fluid during normal and pathological conditions].
    Ferlito S; Reggio A; Pero G; Nicoletti F
    Acta Neurol (Napoli); 1973; 28(6):692-9. PubMed ID: 4783143
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cerebrospinal fluid plasminogen assay in different neurological diseases (author's transl)].
    Aznar JA; Vilches JJ; Mayans JR; Tascón A; Monsalvez F; Marty ML
    Sangre (Barc); 1976; 21(2):225-8. PubMed ID: 948774
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical significance of examination of the oligoclonal bands in cerebrospinal fluid in multiple sclerosis and other neurological disorders].
    Ai KZ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1983 Oct; 16(5):285-8. PubMed ID: 6675952
    [No Abstract]   [Full Text] [Related]  

  • 15. [Molecular diffusion/cerebrospinal fluid flow theory].
    Dorta-Contreras AJ; Reiber H
    Rev Neurol; 2004 Sep 16-30; 39(6):564-9. PubMed ID: 15467996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spectrophotometric analysis of cerebrospinal fluid pigments with special emphasis on fluid in cerebrovascular insult].
    Parag-Nikolić M; Hlavka V; Barac B; Arko K
    Acta Med Iugosl; 1980; 34(3):251-62. PubMed ID: 7468304
    [No Abstract]   [Full Text] [Related]  

  • 17. Application of solid phase extraction and high-performance liquid chromatography to qualitative and quantitative analysis of nucleotides and nucleosides in human cerebrospinal fluid.
    Czarnecka J; Cieślak M; Michał K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 822(1-2):85-90. PubMed ID: 15993662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the cerebrospinal fluid pH in nervous system diseases].
    Zhang CG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Sep; 15(3):167-9. PubMed ID: 7151578
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholesterol content in cerebrospinal fluid of hydrocephalus.
    Wan AT; Carter CH
    Clin Chim Acta; 1966 May; 13(5):546-51. PubMed ID: 5962912
    [No Abstract]   [Full Text] [Related]  

  • 20. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA; Lin J; Sadiq SA
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.